首页 > 最新文献

Reproductive Endocrinology最新文献

英文 中文
Anemia of pregnancy and helicobacteriosis: features of the clinical and laboratory course 妊娠贫血和螺旋杆菌病:临床和实验室病程的特点
Q4 Medicine Pub Date : 2023-09-29 DOI: 10.18370/2309-4117.2023.69.53-58
V. Mishchenko, V. Mishchenko, I.V. Rudenko, I.L. Holovatyuk-Yuzefpolska
A clinical case of the course of pregnancy by trimesters of gestation, childbirth, postpartum (early, late) in a woman with anemia and helicobacteriosis is described. The materials of the medical documentation were analyzed, the peculiarities of the course of pregnancy, childbirth, the postpartum period, laboratory indicators, echography, fibrogastroduodenoscopy were determined.A 32-year-old pregnant woman was hospitalized at 33–34 weeks’ gestation, IV pregnancy. According to the clinical and laboratory examination, B12-folate-iron-deficiency anemia was diagnosed against the background of Helicobacter pylori (Hp) infection (titers of total IgG, IgA, IgM antibodies to Hp antigens (coefficient of positivity) were 7.65). The patient received anti-anemic, nutrient therapy before and after childbirth. Childbirth was termed and physiological. The child was born with a body weight of 3000 g and an Apgar score of 8 points.The woman was examined again 2 months after labor. Anemia of II degree was diagnosed, the Hp coefficient of positivity was increased up to 14.57. It was prescribed anti-anemic therapy aimed at eradicating Hp in accordance with the Maastricht V Consensus (2015) and stabilizing metabolic processes. Two months after treatment, the Hp coefficient of positivity decreased by 2.3 times and the levels of hemoglobin, ferritin, vitamin B12, and folic acid increased to reference values.Conclusions. It is advisable to determine the total titers of IgG, IgA, IgM antibodies to Hp antigens (coefficient of positivity) as the etiological factors of anemia in pregnant women, especially with diseases of the gastrointestinal tract, hepatobiliary system and resistance to anti-anemic therapy. Helicobacteriosis affects the exchange of iron and vitamins of group B, while anemia occurs with more severe manifestations and is resistant to anti-anemic drugs.Full treatment of pregnant women with helicobacteriosis is difficult due to the possible risk of negative effects of etiotropic drugs on the fetus. Therefore, it is important to plan a pregnancy, since timely detection of infectious factors before pregnancy and full-fledged therapy help to reduce the frequency of gestational complications.
本文描述了一个患有贫血和螺旋杆菌病的妇女在妊娠、分娩、产后(早期、晚期)三个月的妊娠过程中的临床病例。对医疗文件材料进行了分析,确定了妊娠、分娩、产后过程的特殊性、实验室指标、超声波检查、纤维胃十二指肠镜检查。一名 32 岁的孕妇在妊娠 33†"34’周时住院,妊娠 IV 期。根据临床和实验室检查,在幽门螺杆菌(Hp)感染的背景下,诊断出 B12-叶酸-缺铁性贫血(Hp 抗原总 IgG、IgA、IgM 抗体滴度(阳性系数)为 7.65)。患者在分娩前后接受了抗贫血和营养治疗。分娩是生理性的。婴儿出生时体重 3000 克,阿普加评分 8 分。诊断为二级贫血,Hp 阳性系数上升到 14.57。根据《马斯特里赫特第五次共识》(2015 年),医生开出了抗贫血治疗处方,旨在根除 Hp 并稳定代谢过程。治疗两个月后,Hp 阳性系数下降了 2.3 倍,血红蛋白、铁蛋白、维生素 B12 和叶酸水平上升至参考值。作为孕妇贫血的致病因素,尤其是患有胃肠道、肝胆系统疾病和抗贫血治疗耐药的孕妇,最好测定 Hp 抗原 IgG、IgA、IgM 抗体的总滴度(阳性系数)。螺旋杆菌病会影响铁和 B 组维生素的交换,而贫血的发生则表现得更为严重,并对抗血 贫药物产生抗药性。由于可能存在致病药物对胎儿产生负面影响的风险,因此很难对患有螺旋 菌病的孕妇进行全面治疗。因此,计划怀孕非常重要,因为在怀孕前及时发现感染因素并进行全面治疗有助于降低妊娠并发症的发生率。
{"title":"Anemia of pregnancy and helicobacteriosis: features of the clinical and laboratory course","authors":"V. Mishchenko, V. Mishchenko, I.V. Rudenko, I.L. Holovatyuk-Yuzefpolska","doi":"10.18370/2309-4117.2023.69.53-58","DOIUrl":"https://doi.org/10.18370/2309-4117.2023.69.53-58","url":null,"abstract":"A clinical case of the course of pregnancy by trimesters of gestation, childbirth, postpartum (early, late) in a woman with anemia and helicobacteriosis is described. The materials of the medical documentation were analyzed, the peculiarities of the course of pregnancy, childbirth, the postpartum period, laboratory indicators, echography, fibrogastroduodenoscopy were determined.A 32-year-old pregnant woman was hospitalized at 33–34 weeks’ gestation, IV pregnancy. According to the clinical and laboratory examination, B12-folate-iron-deficiency anemia was diagnosed against the background of Helicobacter pylori (Hp) infection (titers of total IgG, IgA, IgM antibodies to Hp antigens (coefficient of positivity) were 7.65). The patient received anti-anemic, nutrient therapy before and after childbirth. Childbirth was termed and physiological. The child was born with a body weight of 3000 g and an Apgar score of 8 points.The woman was examined again 2 months after labor. Anemia of II degree was diagnosed, the Hp coefficient of positivity was increased up to 14.57. It was prescribed anti-anemic therapy aimed at eradicating Hp in accordance with the Maastricht V Consensus (2015) and stabilizing metabolic processes. Two months after treatment, the Hp coefficient of positivity decreased by 2.3 times and the levels of hemoglobin, ferritin, vitamin B12, and folic acid increased to reference values.Conclusions. It is advisable to determine the total titers of IgG, IgA, IgM antibodies to Hp antigens (coefficient of positivity) as the etiological factors of anemia in pregnant women, especially with diseases of the gastrointestinal tract, hepatobiliary system and resistance to anti-anemic therapy. Helicobacteriosis affects the exchange of iron and vitamins of group B, while anemia occurs with more severe manifestations and is resistant to anti-anemic drugs.Full treatment of pregnant women with helicobacteriosis is difficult due to the possible risk of negative effects of etiotropic drugs on the fetus. Therefore, it is important to plan a pregnancy, since timely detection of infectious factors before pregnancy and full-fledged therapy help to reduce the frequency of gestational complications.","PeriodicalId":21103,"journal":{"name":"Reproductive Endocrinology","volume":"27 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139334471","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Theranostics of uterine leiomyoma: present and future 子宫肌瘤的血清疗法:现状与未来
Q4 Medicine Pub Date : 2023-09-29 DOI: 10.18370/2309-4117.2023.69.95-103
О.С. Салех, D. Zhelezov, I. Hladchuk, A. Volyanska
Research objectives: to develop an algorithm for predicting the growth of uterine fibrodis, taking into account the state of epigenetic regulation.Materials and methods. The study was conducted on the basis of clinical divisions of the Department of Obstetrics and Gynecology in 2018–2021. 28 patients with uterine fibroids were examined. Expression of miRNA-29b and miRNA-146a in tumor tissue was determined in all women using real-time PCR. Obtained data were analyzed using the statistical program Statistica 10.0 (StatSoft Inc., USA).Results. The average age of the patients was 39.3 ± 1.0 years. The average number of nodes was 2.7 ± 0.4. The expression levels of microRNA-29b were most frequently determined in the range of 2–7 units and microRNA-146a in the range of 30–67 units in most of the examined tissue samples. The expression of miRNA-29b has the greatest significance for the growth forecast (Wald statistic). According to the logistic regression equation the prognostic factors are patient’s age, estradiol and progesterone level in the I and II phases of the menstrual cycle, diameter of the largest node, expression of miRNA-29b and miRNA-146a.Conclusions. This study shows that the use of miRNA expression profile as an additional marker in the diagnosis and treatment of uterine fibroids is promising and requires more detailed research. Further study of the correlation of clinical and paraclinical parameters can make it possible to predict the course of uterine fibroids, and therefore to apply an effective personalized treatment plan. Theranostics is a new approach to the diagnosis and treatment of patients, based on the uniqueness of each person in order to choose the optimal treatment strategy against the background of the molecular genetic technologies, in particular to determine epigenetic changes in hyperproliferative diseases. The study of miRNA expression may find its place in the theranostics of uterine fibroids in the future.
研究目的:在考虑表观遗传调控状态的基础上,开发一种预测子宫肌瘤生长的算法。该研究是在2018-2021年妇产科临床分科的基础上进行的。对28例子宫肌瘤患者进行了检查。利用实时PCR技术测定了所有女性肿瘤组织中miRNA-29b和miRNA-146a的表达情况。获得的数据使用 Statistica 10.0 统计程序(StatSoft Inc.患者的平均年龄为 39.3 ± 1.0 岁。平均结节数为 2.7 ± 0.4。在大多数受检组织样本中,microRNA-29b 的表达水平通常在 2-7 个单位之间,microRNA-146a 的表达水平通常在 30-67 个单位之间。miRNA-29b 的表达对生长预测的意义最大(Wald 统计)。根据逻辑回归方程,预后因素包括患者的年龄、月经周期 I 期和 II 期的雌二醇和孕酮水平、最大结节的直径、miRNA-29b 和 miRNA-146a 的表达。这项研究表明,使用 miRNA 表达谱作为诊断和治疗子宫肌瘤的额外标志物很有前景,但还需要更详细的研究。进一步研究临床和辅助临床参数的相关性,可以预测子宫肌瘤的病程,从而制定有效的个性化治疗方案。Theranostics 是一种诊断和治疗病人的新方法,它以每个人的独特性为基础,以便在分子遗传技术的背景下选择最佳治疗策略,特别是确定过度增殖性疾病的表观遗传变化。未来,miRNA 表达研究可能会在子宫肌瘤的治疗学中占有一席之地。
{"title":"Theranostics of uterine leiomyoma: present and future","authors":"О.С. Салех, D. Zhelezov, I. Hladchuk, A. Volyanska","doi":"10.18370/2309-4117.2023.69.95-103","DOIUrl":"https://doi.org/10.18370/2309-4117.2023.69.95-103","url":null,"abstract":"Research objectives: to develop an algorithm for predicting the growth of uterine fibrodis, taking into account the state of epigenetic regulation.Materials and methods. The study was conducted on the basis of clinical divisions of the Department of Obstetrics and Gynecology in 2018–2021. 28 patients with uterine fibroids were examined. Expression of miRNA-29b and miRNA-146a in tumor tissue was determined in all women using real-time PCR. Obtained data were analyzed using the statistical program Statistica 10.0 (StatSoft Inc., USA).Results. The average age of the patients was 39.3 ± 1.0 years. The average number of nodes was 2.7 ± 0.4. The expression levels of microRNA-29b were most frequently determined in the range of 2–7 units and microRNA-146a in the range of 30–67 units in most of the examined tissue samples. The expression of miRNA-29b has the greatest significance for the growth forecast (Wald statistic). According to the logistic regression equation the prognostic factors are patient’s age, estradiol and progesterone level in the I and II phases of the menstrual cycle, diameter of the largest node, expression of miRNA-29b and miRNA-146a.Conclusions. This study shows that the use of miRNA expression profile as an additional marker in the diagnosis and treatment of uterine fibroids is promising and requires more detailed research. Further study of the correlation of clinical and paraclinical parameters can make it possible to predict the course of uterine fibroids, and therefore to apply an effective personalized treatment plan. Theranostics is a new approach to the diagnosis and treatment of patients, based on the uniqueness of each person in order to choose the optimal treatment strategy against the background of the molecular genetic technologies, in particular to determine epigenetic changes in hyperproliferative diseases. The study of miRNA expression may find its place in the theranostics of uterine fibroids in the future.","PeriodicalId":21103,"journal":{"name":"Reproductive Endocrinology","volume":"42 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139334066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Magnesium at physiological pregnancy and at its complications 镁在生理妊娠及其并发症中的作用
Q4 Medicine Pub Date : 2023-09-29 DOI: 10.18370/2309-4117.2023.69.41-52
V.F. Nagorna, T.A. Kulish
Sources of literature on the role of the trace element magnesium and the assosiation with calcium in physiological processes in the body of reproductive aged women and pregnant women, the importance of its main functions and role in preventing the main pregnancy complications were analyzed. Magnesium is the fourth most important extracellular cation after sodium, potassium and calcium and the second intracellular cation in importance after potassium. Many researchers have proven the participation of magnesium in almost everyone important functions in the body. Magnesium performs the following functions which are closely interconnected: metabolic, energetic, enzymatic, cardiovascular, antithrombotic, vascular, neuroprotective, structural, is an antagonist of calcium and an agonist of NMDA receptors. Magnesium realizes its functions in close interaction with cations of sodium, potassium and calcium. It acts as a calcium antagonist. It should be noted attention to the understanding of the interaction of divalent cations-competitors of magnesium and calcium. Calcium has complex influences on interaction of magnesium with blood proteins, reduces its concentration, which can affect physiological processes during pregnancy and in non-pregnant women. Today, magnesium is used only for prevention and treatment of eclampsia, in which anticonvulsants are commonly used ineffective. It can be assumed that different convulsive states have different intracellularly or extracellularly magnesium concentration is important in the pathogenesis and occurrence of eclampsia. Determination of magnesium concentration never was indicated in the recommendations for the management of preeclampsia. Magnesium use is insufficiently substantiated in cases of uterus contraction activity in any conditions (threat of abortion, premature birth) and prevention of pathological blood clot formation (as causes of multiple complications of pregnancy), neuroprotective effect on a child. The role of magnesium in the production of steroid hormones has been proven. However, this effect remains unrealized in obstetrics and gynecology practice. Data from literature sources given in the article help justify the use of magnesium and analyze its interaction with calcium during pregnancy.
本研究分析了微量元素镁在育龄妇女和孕妇体内生理过程中的作用及其与钙的关系、镁的主要功能的重要性以及在预防主要妊娠并发症方面的作用。 镁是仅次于钠、钾和钙的第四大细胞外阳离子,也是仅次于钾的第二大细胞内阳离子。许多研究人员已经证明,镁几乎参与了人体内所有重要的功能。镁具有以下密切相关的功能:代谢、能量、酶、心血管、抗血栓、血管、神经保护、结构、钙拮抗剂和 NMDA 受体激动剂。镁在与钠、钾和钙等阳离子的密切相互作用中实现其功能。镁是钙的拮抗剂。应注意了解二价阳离子--镁和钙的竞争者--之间的相互作用。钙对镁与血液蛋白质的相互作用有复杂的影响,会降低镁的浓度,从而影响孕期和非孕期妇女的生理过程。 如今,镁仅用于预防和治疗子痫,而抗惊厥药通常对子痫无效。可以认为,不同的抽搐状态有不同的细胞内或细胞外镁浓度,这对子痫的发病机制和发生非常重要。在子痫前期的治疗建议中从未提及镁浓度的测定。在任何情况下子宫收缩活动(流产、早产的威胁)、预防病理性血凝块的形成(妊娠多种并发症的原因)、对婴儿的神经保护作用等方面,镁的使用都没有得到充分证实。 镁在类固醇激素分泌中的作用已得到证实。然而,这种作用在妇产科实践中仍未得到体现。 文章中提供的文献资料有助于证明镁在孕期的使用并分析其与钙的相互作用。
{"title":"Magnesium at physiological pregnancy and at its complications","authors":"V.F. Nagorna, T.A. Kulish","doi":"10.18370/2309-4117.2023.69.41-52","DOIUrl":"https://doi.org/10.18370/2309-4117.2023.69.41-52","url":null,"abstract":"Sources of literature on the role of the trace element magnesium and the assosiation with calcium in physiological processes in the body of reproductive aged women and pregnant women, the importance of its main functions and role in preventing the main pregnancy complications were analyzed. Magnesium is the fourth most important extracellular cation after sodium, potassium and calcium and the second intracellular cation in importance after potassium. Many researchers have proven the participation of magnesium in almost everyone important functions in the body. Magnesium performs the following functions which are closely interconnected: metabolic, energetic, enzymatic, cardiovascular, antithrombotic, vascular, neuroprotective, structural, is an antagonist of calcium and an agonist of NMDA receptors. Magnesium realizes its functions in close interaction with cations of sodium, potassium and calcium. It acts as a calcium antagonist. It should be noted attention to the understanding of the interaction of divalent cations-competitors of magnesium and calcium. Calcium has complex influences on interaction of magnesium with blood proteins, reduces its concentration, which can affect physiological processes during pregnancy and in non-pregnant women. Today, magnesium is used only for prevention and treatment of eclampsia, in which anticonvulsants are commonly used ineffective. It can be assumed that different convulsive states have different intracellularly or extracellularly magnesium concentration is important in the pathogenesis and occurrence of eclampsia. Determination of magnesium concentration never was indicated in the recommendations for the management of preeclampsia. Magnesium use is insufficiently substantiated in cases of uterus contraction activity in any conditions (threat of abortion, premature birth) and prevention of pathological blood clot formation (as causes of multiple complications of pregnancy), neuroprotective effect on a child. The role of magnesium in the production of steroid hormones has been proven. However, this effect remains unrealized in obstetrics and gynecology practice. Data from literature sources given in the article help justify the use of magnesium and analyze its interaction with calcium during pregnancy.","PeriodicalId":21103,"journal":{"name":"Reproductive Endocrinology","volume":"43 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139334091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Phytocompositions of ayurvedic medicine in the restoration of menstrual health in women of early reproductive age who have survived moderate and severe form of COVID-19 阿育吠陀药的植物成分在恢复中度和重度 COVID-19 病例中育龄妇女的月经健康方面的作用
Q4 Medicine Pub Date : 2023-09-29 DOI: 10.18370/2309-4117.2023.69.104-112
O.M. Nosenko, T.Ya. Moskalenko, E. Chaykivska, Din Tkhi Suan Ni
Research objectives: to evaluate the effectiveness of phytotherapy in the treatment of menstrual health disorders in women of early reproductive age after a moderate and severe form of the coronavirus disease.Material and methods. 104 women of early reproductive age with menstrual health disorders that occurred 3 months later after moderate or severe COVID-19 were under observation and 34 gynecologically and somatically healthy women of the control group who did not suffer from COVID-19. Female patients with COVID-19 were randomly divided into two groups: the main group (n=53) and the comparison group (n=51). The performed examination included: study of complaints, general and gynecological anamnesis, physical and gynecological examination, ultrasound examination of pelvic organs, determination of hormonal profile. All patients with COVID-19 received a comprehensive rehabilitation program, which included diet therapy, vitamin and mineral complexes, psychotherapy. In addition to the complex rehabilitation program patients of the main group received ayurvedic phytocompositions Femicycle or Femimens for 6 months.Results. It has been established that the moderate and severe course of the coronavirus infection affects the reproductive system of early reproductive aged women and leads to menstrual health disorders, among which irregular menstruation, premenstrual syndrome and dysmenorrhea dominate. Levels of pituitary, adrenal, ovarian and thyroid serum hormones were within the reference norm in most cases, but have statistically significant deviations from similar indicators of healthy control women who did not have COVID-19. One-third of women of early reproductive age after moderate to severe COVID-19 had elevated prolactin levels. Ayurvedic phytocompositions Femicycle and Femimens in a comprehensive rehabilitation program for post-COVID menstrual health disorders led to a faster recovery of menstrual health and a full hormonal recovery.Conclusions. Ayurvedic phytocompositions Femicycle and Femimens are effective and safe naturopathic drugs for restoring menstrual health in women of early reproductive age after experiencing moderate to severe COVID-19.
研究目的:评估植物疗法对中度和重度冠状病毒病后育龄期妇女月经紊乱的治疗效果。观察 104 名在中度或重度 COVID-19 后 3 个月出现月经紊乱的育龄妇女,以及 34 名未患 COVID-19 的妇科和躯体健康的对照组妇女。COVID-19 女性患者被随机分为两组:主要组(53 人)和对比组(51 人)。进行的检查包括:主诉研究、一般和妇科病史、体格和妇科检查、盆腔器官超声波检查、激素水平测定。所有 COVID-19 患者都接受了综合康复计划,其中包括饮食疗法、复合维生素和矿物质以及心理疗法。除了综合康复计划外,主要组患者还接受了为期6个月的阿育吠陀植物成分 Femicycle 或 Femimens。已经证实,冠状病毒感染的中度和重度病程会影响育龄妇女的生殖系统,导致月经失调,其中以月经不调、经前综合征和痛经为主。大多数病例的垂体、肾上腺、卵巢和甲状腺血清激素水平在参考标准范围内,但与未感染 COVID-19 的健康对照组妇女的类似指标相比,有显著的统计学偏差。三分之一患有中度至重度 COVID-19 的育龄妇女催乳素水平升高。阿育吠陀植物复合制剂 Femicycle 和 Femimens 在治疗 COVID-19 后月经健康紊乱的综合康复计划中的应用,使月经健康恢复得更快,荷尔蒙完全恢复。阿育吠陀植物复合制剂Femicycle和Femimens是一种有效、安全的自然疗法药物,可帮助经历中度至重度COVID-19后的育龄妇女恢复月经健康。
{"title":"Phytocompositions of ayurvedic medicine in the restoration of menstrual health in women of early reproductive age who have survived moderate and severe form of COVID-19","authors":"O.M. Nosenko, T.Ya. Moskalenko, E. Chaykivska, Din Tkhi Suan Ni","doi":"10.18370/2309-4117.2023.69.104-112","DOIUrl":"https://doi.org/10.18370/2309-4117.2023.69.104-112","url":null,"abstract":"Research objectives: to evaluate the effectiveness of phytotherapy in the treatment of menstrual health disorders in women of early reproductive age after a moderate and severe form of the coronavirus disease.Material and methods. 104 women of early reproductive age with menstrual health disorders that occurred 3 months later after moderate or severe COVID-19 were under observation and 34 gynecologically and somatically healthy women of the control group who did not suffer from COVID-19. Female patients with COVID-19 were randomly divided into two groups: the main group (n=53) and the comparison group (n=51). The performed examination included: study of complaints, general and gynecological anamnesis, physical and gynecological examination, ultrasound examination of pelvic organs, determination of hormonal profile. All patients with COVID-19 received a comprehensive rehabilitation program, which included diet therapy, vitamin and mineral complexes, psychotherapy. In addition to the complex rehabilitation program patients of the main group received ayurvedic phytocompositions Femicycle or Femimens for 6 months.Results. It has been established that the moderate and severe course of the coronavirus infection affects the reproductive system of early reproductive aged women and leads to menstrual health disorders, among which irregular menstruation, premenstrual syndrome and dysmenorrhea dominate. Levels of pituitary, adrenal, ovarian and thyroid serum hormones were within the reference norm in most cases, but have statistically significant deviations from similar indicators of healthy control women who did not have COVID-19. One-third of women of early reproductive age after moderate to severe COVID-19 had elevated prolactin levels. Ayurvedic phytocompositions Femicycle and Femimens in a comprehensive rehabilitation program for post-COVID menstrual health disorders led to a faster recovery of menstrual health and a full hormonal recovery.Conclusions. Ayurvedic phytocompositions Femicycle and Femimens are effective and safe naturopathic drugs for restoring menstrual health in women of early reproductive age after experiencing moderate to severe COVID-19.","PeriodicalId":21103,"journal":{"name":"Reproductive Endocrinology","volume":"8 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139334490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resolution of the IV International Menopause Expert Forum 第四届国际更年期专家论坛决议
Q4 Medicine Pub Date : 2023-09-29 DOI: 10.18370/2309-4117.2023.69.2-6
The IV International Menopause Expert Forum took place on November 24, 2022. The expert panel included leading endocrine gynaecologists from Armenia, Azerbaijan, Georgia, Kazakhstan, Moldova, Ukraine, Uzbekistan, and Ukraine. The experts discussed interdisciplinary cooperation in the management of menopausal women, the eligibility criteria for menopausal hormone therapy (MHT) and their implementation in routine clinical practice and developed an algorithm for switching from combined oral contraceptives (COCs) to MHT. Due to the lack of awareness and access to information and services related to menopause, interdisciplinary cooperation aimed at early detection of symptoms and diagnosis of menopausal disorders for timely treatment is paramount. The Forum participants highlighted the need for a series of steps to ensure comprehensive management of menopausal women. The Expert Forum reviewed the 2022 «Eligibility criteria for menopausal hormone therapy: a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions». The developed criteria for the acceptability of different MHT types for women with comorbidities is an essential step in expanding the possibilities for the use of MHT by physicians of various therapeutic areas. Moreover, the criteria help to identify populations for whom certain types of MHT are associated with risks. Importantly, the discussed eligibility criteria are not yet universally accepted. Therefore, in routine clinical practice, when deciding whether to prescribe a particular type of MHT, it is vital to take an individual approach and assess the benefit/risk balance, considering the patient’s combination of comorbidities, medical history, as well as the strengths and components of combination MHT, particularly the gestational component.Perimenopausal women may need contraception, including COCs. In such circumstances, physicians are faced with such questions as the acceptability of prescribing or continuing to use COCs for menopausal women, as well as when and how to switch from COCs to MHT. Thus, the Forum developed an algorithm for switching from COCs to MHT.
第四届国际更年期专家论坛于 2022 年 11 月 24 日举行。专家小组成员包括来自亚美尼亚、阿塞拜疆、格鲁吉亚、哈萨克斯坦、摩尔多瓦、乌克兰、乌兹别克斯坦和乌克兰的顶尖妇科内分泌专家。专家们讨论了更年期妇女管理中的跨学科合作、更年期激素疗法(MHT)的资格标准及其在常规临床实践中的实施,并制定了从复方口服避孕药(COCs)转向更年期激素疗法的算法。由于缺乏对更年期相关信息和服务的了解和获取途径,旨在早期发现更年期症状和诊断更年期失调以进行及时治疗的跨学科合作至关重要。论坛与会者强调有必要采取一系列措施,确保对更年期妇女进行全面管理。专家论坛审查了 2022 年 "更年期激素疗法的资格标准:科学协会联合会关于在有病症的妇女中使用更年期激素疗法的立场声明"。为有合并症的妇女制定的不同类型更年期激素疗法的可接受性标准是扩大不同治疗领域的医生使用更年期激素疗法的可能性的重要一步。此外,这些标准还有助于确定某些类型的人工晶体植入术对哪些人群具有风险。重要的是,所讨论的资格标准尚未得到普遍接受。因此,在常规临床实践中,在决定是否开具特定类型的 MHT 时,必须采取因人而异的方法,评估收益/风险的平衡,考虑患者的合并症、病史以及联合 MHT 的优势和组成部分,尤其是妊娠组成部分。在这种情况下,医生面临着为绝经期妇女开具或继续使用 COCs 的可接受性,以及何时和如何从 COCs 转为 MHT 等问题。因此,论坛制定了一个从 COCs 转为 MHT 的算法。
{"title":"Resolution of the IV International Menopause Expert Forum","authors":"","doi":"10.18370/2309-4117.2023.69.2-6","DOIUrl":"https://doi.org/10.18370/2309-4117.2023.69.2-6","url":null,"abstract":"The IV International Menopause Expert Forum took place on November 24, 2022. The expert panel included leading endocrine gynaecologists from Armenia, Azerbaijan, Georgia, Kazakhstan, Moldova, Ukraine, Uzbekistan, and Ukraine. The experts discussed interdisciplinary cooperation in the management of menopausal women, the eligibility criteria for menopausal hormone therapy (MHT) and their implementation in routine clinical practice and developed an algorithm for switching from combined oral contraceptives (COCs) to MHT. Due to the lack of awareness and access to information and services related to menopause, interdisciplinary cooperation aimed at early detection of symptoms and diagnosis of menopausal disorders for timely treatment is paramount. The Forum participants highlighted the need for a series of steps to ensure comprehensive management of menopausal women. The Expert Forum reviewed the 2022 «Eligibility criteria for menopausal hormone therapy: a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions». The developed criteria for the acceptability of different MHT types for women with comorbidities is an essential step in expanding the possibilities for the use of MHT by physicians of various therapeutic areas. Moreover, the criteria help to identify populations for whom certain types of MHT are associated with risks. Importantly, the discussed eligibility criteria are not yet universally accepted. Therefore, in routine clinical practice, when deciding whether to prescribe a particular type of MHT, it is vital to take an individual approach and assess the benefit/risk balance, considering the patient’s combination of comorbidities, medical history, as well as the strengths and components of combination MHT, particularly the gestational component.Perimenopausal women may need contraception, including COCs. In such circumstances, physicians are faced with such questions as the acceptability of prescribing or continuing to use COCs for menopausal women, as well as when and how to switch from COCs to MHT. Thus, the Forum developed an algorithm for switching from COCs to MHT.","PeriodicalId":21103,"journal":{"name":"Reproductive Endocrinology","volume":"28 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139334057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modern possibilities of correcting violations of the vaginal biotope in pregnant women at risk in wartime conditions 在战时条件下纠正高危孕妇阴道生物群侵犯的现代可能性
Q4 Medicine Pub Date : 2023-09-29 DOI: 10.18370/2309-4117.2023.69.30-35
I. A. Zhabchenko, V. Lihachov, I. Lishchenko, O.M. Bondarenko, T.M. Kovalenko
Research objective: to determine the effectiveness of a complex local preparation with antiseptic action based on octenidine and repair agent dexpanthenol (Prodexyn) in the syndrome of abnormal vaginal discharge (AVD) in pregnant women with obstetric pathology during the gestation and in the sanitation of the birth canal on the eve of childbirth. Materials and methods. 49 pregnant women were examined and divided into 2 groups: group I – 21 women (including 6 pregnant women with the status of internally displaced persons (IDPs)) with AVD in the period of 14–36 weeks of pregnancy; group II – 28 pregnant women (15 of them IDPs) on the eve of childbirth, who needed sanitation of the birth canal in the period of 37-41 weeks. The selection of patients was based on complaints, objective examination in mirrors and determination of vaginal pH. A bacterioscopic and bacteriological study was carried out if the pH deviates from the norm in order to identify pathogens and control the treatment effectiveness. Prodexyn was prescribed to all women in the vaginal suppositories at night for 10 days from the II trimester of pregnancy. Results. Most of women had a complicated obstetric and gynecological history, chronic inflammatory diseases of the pelvic organs, and viral infections. 87.7% of women had obstetric complications during current pregnancy. In the group I the primary average value of vaginal pH was 4.94 ± 0.02, and was the highest in IDPs (5.0-5.3). In the group II the pH before delivery at the initial screening was 5.1 ± 0.03, and in IDPs it was 5.7. Bacterioscopic examination in both groups showed a large number of leukocytes, cocci and fungal flora. Bacteriological examination in both groups showed a total of 11 pathogenic and opportunistic pathogens in various 2–3 component microbial and microbial-fungal associations against the background of a significant decrease in the number of lactobacilli. Single cases of Staphylococcus aureus and Streptococcus agalactiae (in group I) and Streptococcus viridans (in group II) were found. After sanitation the state of the vaginal biotope significantly improved in the majority of pregnant women of both groups. pH in group I was 4.51 ± 0.013, in group II was 4.55 ± 0.03. According to bacterioscopy, the number of leukocytes, coccal, bacillus and fungal flora significantly decreased in both groups. Bacteriological examination showed positive dynamics of the microflora concentration and the amount of its species spectrum. The lactobacilli concentration increased in both groups. Worse indicators of the vaginal biotope restoration were observed in IDPs, especially in the I group in the II–III trimesters, which required an extension of the treatment course for another 5–10 days. Conclusions. The complex local preparation with antiseptic action Prodexyn for AVD in pregnant women with obstetric pathology has shown its effectiveness and safety. As a result of the treatment, the number of pathogenic and conditionally pa
研究目的:确定以辛烯胺和修复剂脱泛醇(Prodexyn)为基础的具有杀菌作用的复合局部制剂对妊娠期产科病变孕妇的异常阴道分泌物综合症(AVD)和分娩前夕产道卫生的有效性。 材料和方法对 49 名孕妇进行了检查,并将其分为两组:第一组--21 名孕妇(包括 6 名境内流离失所者孕妇)在妊娠 14-36 周期间患有阴道异常分泌物;第二组--28 名孕妇(其中 15 名境内流离失所者)在分娩前夕,需要在 37-41 周期间进行产道卫生处理。根据主诉、镜下客观检查和阴道 pH 值的测定来选择患者。如果 pH 值偏离正常值,则进行细菌镜检查和细菌学研究,以确定病原体并控制治疗效果。所有妇女从怀孕后三个月开始,每晚使用 Prodexyn 阴道栓剂,连续使用 10 天。 结果大多数妇女有复杂的妇产科病史、盆腔器官慢性炎症和病毒感染。87.7%的妇女在本次妊娠期间出现过产科并发症。 在第一组中,阴道 pH 的原始平均值为 4.94 ± 0.02,在国内流离失所者中最高(5.0-5.3)。在第二组中,初筛时分娩前的 pH 值为 5.1 ± 0.03,而在 IDPs 中为 5.7。两组的细菌学检查均显示有大量白细胞、球菌和真菌菌群。细菌学检查显示,在乳酸杆菌数量显著减少的背景下,两组人群中共有 11 种致病菌和机会致病菌,它们以不同的 2-3 种微生物成分和微生物-真菌组合形式存在。发现了金黄色葡萄球菌和无乳链球菌(第一组)以及病毒性链球菌(第二组)。 两组中大多数孕妇的阴道生物环境在消毒后都得到了明显改善,第一组的 pH 值为 4.51 ± 0.013,第二组为 4.55 ± 0.03。细菌学检查显示,两组孕妇的白细胞、球菌、杆菌和真菌数量均明显减少。细菌学检查显示,微生物菌群的浓度及其物种谱的数量呈正动态变化。两组的乳酸杆菌浓度都有所上升。在 IDPs 中观察到的阴道生物群恢复指标较差,尤其是在 II-3 三个月的 I 组中,这就需要将疗程再延长 5-10 天。 结论具有杀菌作用的复合局部制剂 Prodexyn 对患有产科病变的孕妇的 AVD 治疗显示出其有效性和安全性。经过治疗后,致病菌群和条件致病菌群的数量明显减少,同时溶菌菌群和LacISSN 2309-4117tobacilli的浓度有所增加。
{"title":"Modern possibilities of correcting violations of the vaginal biotope in pregnant women at risk in wartime conditions","authors":"I. A. Zhabchenko, V. Lihachov, I. Lishchenko, O.M. Bondarenko, T.M. Kovalenko","doi":"10.18370/2309-4117.2023.69.30-35","DOIUrl":"https://doi.org/10.18370/2309-4117.2023.69.30-35","url":null,"abstract":"Research objective: to determine the effectiveness of a complex local preparation with antiseptic action based on octenidine and repair agent dexpanthenol (Prodexyn) in the syndrome of abnormal vaginal discharge (AVD) in pregnant women with obstetric pathology during the gestation and in the sanitation of the birth canal on the eve of childbirth. Materials and methods. 49 pregnant women were examined and divided into 2 groups: group I – 21 women (including 6 pregnant women with the status of internally displaced persons (IDPs)) with AVD in the period of 14–36 weeks of pregnancy; group II – 28 pregnant women (15 of them IDPs) on the eve of childbirth, who needed sanitation of the birth canal in the period of 37-41 weeks. The selection of patients was based on complaints, objective examination in mirrors and determination of vaginal pH. A bacterioscopic and bacteriological study was carried out if the pH deviates from the norm in order to identify pathogens and control the treatment effectiveness. Prodexyn was prescribed to all women in the vaginal suppositories at night for 10 days from the II trimester of pregnancy. Results. Most of women had a complicated obstetric and gynecological history, chronic inflammatory diseases of the pelvic organs, and viral infections. 87.7% of women had obstetric complications during current pregnancy. In the group I the primary average value of vaginal pH was 4.94 ± 0.02, and was the highest in IDPs (5.0-5.3). In the group II the pH before delivery at the initial screening was 5.1 ± 0.03, and in IDPs it was 5.7. Bacterioscopic examination in both groups showed a large number of leukocytes, cocci and fungal flora. Bacteriological examination in both groups showed a total of 11 pathogenic and opportunistic pathogens in various 2–3 component microbial and microbial-fungal associations against the background of a significant decrease in the number of lactobacilli. Single cases of Staphylococcus aureus and Streptococcus agalactiae (in group I) and Streptococcus viridans (in group II) were found. After sanitation the state of the vaginal biotope significantly improved in the majority of pregnant women of both groups. pH in group I was 4.51 ± 0.013, in group II was 4.55 ± 0.03. According to bacterioscopy, the number of leukocytes, coccal, bacillus and fungal flora significantly decreased in both groups. Bacteriological examination showed positive dynamics of the microflora concentration and the amount of its species spectrum. The lactobacilli concentration increased in both groups. Worse indicators of the vaginal biotope restoration were observed in IDPs, especially in the I group in the II–III trimesters, which required an extension of the treatment course for another 5–10 days. Conclusions. The complex local preparation with antiseptic action Prodexyn for AVD in pregnant women with obstetric pathology has shown its effectiveness and safety. As a result of the treatment, the number of pathogenic and conditionally pa","PeriodicalId":21103,"journal":{"name":"Reproductive Endocrinology","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139334211","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preservation of the reproductive health of military women: global experience and realities of Ukraine 保护女军人的生殖健康:全球经验与乌克兰现实
Q4 Medicine Pub Date : 2023-09-29 DOI: 10.18370/2309-4117.2023.69.8-15
Y. Antypkin, I. Lurin, T. Tatarchuk, N. Kosei, V.M. Yakimets, O.Y. Nazarenko, T.E. Krysenko, Y.M. Bondarenko
A review of world literature and Ukrainian researches on the most common requests to gynecologists among military women, on the structure of pathology and treatment methods was made. Special attention is paid to the hormonal contraception, namely combined oral contraceptives (COCs) in the usual and continuous regime (avoiding the hormone-free interval) and the levonorgestrel-releasing intrauterine systems (LNG-IUDs).Cases of global practice of using COCs in extended regimen were considered, which showed that 47.2% of 1156 women chose a prolonged regimen of COCs, the main reason for this was the desire to avoid symptoms associated with menstruation. We consider this option very positive for military women, because some studies show that military women who took COCs in a continuous regimen were almost twice as favorable to their reception as those who used them in a regular mode.The positive aspects of the LNG-IUDs use in military women are presented, as a factor in the prevention of abnormal uterine bleeding, reducing the risk of iron deficiency in case of possible blood loss, and reducing the intensity of dysmenorrhea as a negative factor in the military conditions.Ways to increase compliance between a gynecologist and a military woman are also considered, using the example of global studies, which prove that insufficient awareness of patients about the possible ways and positive effects of using COCs in extended regimen reduced patients’ commitment to choosing new regimens.Conclusions. In today’s realities, the gynecological service in our country faces a number of new problems that require a strategic approach and solution. World practice and national studies prove that stress-induced hormonal disorders in military women, such as abnormal uterine bleeding, menstrual cycle disorders, dysmenorrhea, are negative factors in combat conditions, require the attention and resolution by doctors. One of the options for solving this problem can be the appointment of COCs according to the usual and extended scheme or appointment of LNG-IUDs.
对世界文献和乌克兰关于女军人向妇科医生提出的最常见要求、病理结构和治疗方法的研究进行了综述。特别关注的是激素避孕,即常规和连续方案(避免无激素间歇期)中的复方口服避孕药(COCs)和左炔诺孕酮释放宫内节育器(LNG-IUDs)。研究考虑了全球延长方案中使用 COCs 的案例,结果显示 1156 名妇女中有 47.2%选择了延长方案中的 COCs,其主要原因是希望避免与月经有关的症状。我们认为这种选择对女军人来说是非常积极的,因为一些研究表明,连续服用 COCs 的女军人对这种药物的接受程度几乎是定期使用的女军人的两倍。LNG-宫内节育器在女军人中使用的积极方面包括:预防异常子宫出血;降低可能失血时缺铁的风险;降低军事条件下痛经这一消极因素的强度。此外,还考虑了如何提高妇科医生和女军人之间的依从性,以全球研究为例,这些研究证明,患者对在延长疗程中使用 COCs 的可能方式和积极作用认识不足,从而降低了患者选择新疗程的决心。在当今的现实情况下,我国的妇科服务面临着许多新问题,需要采取战略性的方法加以解决。世界实践和国内研究证明,应激引起的女军人内分泌失调,如异常子宫出血、月经周期紊乱、痛经等,是作战条件下的负面因素,需要引起医生的重视并加以解决。解决这一问题的方案之一可以是按照常规和扩展方案使用宫内节育器或使用液化天然气宫内节育器。
{"title":"Preservation of the reproductive health of military women: global experience and realities of Ukraine","authors":"Y. Antypkin, I. Lurin, T. Tatarchuk, N. Kosei, V.M. Yakimets, O.Y. Nazarenko, T.E. Krysenko, Y.M. Bondarenko","doi":"10.18370/2309-4117.2023.69.8-15","DOIUrl":"https://doi.org/10.18370/2309-4117.2023.69.8-15","url":null,"abstract":"A review of world literature and Ukrainian researches on the most common requests to gynecologists among military women, on the structure of pathology and treatment methods was made. Special attention is paid to the hormonal contraception, namely combined oral contraceptives (COCs) in the usual and continuous regime (avoiding the hormone-free interval) and the levonorgestrel-releasing intrauterine systems (LNG-IUDs).Cases of global practice of using COCs in extended regimen were considered, which showed that 47.2% of 1156 women chose a prolonged regimen of COCs, the main reason for this was the desire to avoid symptoms associated with menstruation. We consider this option very positive for military women, because some studies show that military women who took COCs in a continuous regimen were almost twice as favorable to their reception as those who used them in a regular mode.The positive aspects of the LNG-IUDs use in military women are presented, as a factor in the prevention of abnormal uterine bleeding, reducing the risk of iron deficiency in case of possible blood loss, and reducing the intensity of dysmenorrhea as a negative factor in the military conditions.Ways to increase compliance between a gynecologist and a military woman are also considered, using the example of global studies, which prove that insufficient awareness of patients about the possible ways and positive effects of using COCs in extended regimen reduced patients’ commitment to choosing new regimens.Conclusions. In today’s realities, the gynecological service in our country faces a number of new problems that require a strategic approach and solution. World practice and national studies prove that stress-induced hormonal disorders in military women, such as abnormal uterine bleeding, menstrual cycle disorders, dysmenorrhea, are negative factors in combat conditions, require the attention and resolution by doctors. One of the options for solving this problem can be the appointment of COCs according to the usual and extended scheme or appointment of LNG-IUDs.","PeriodicalId":21103,"journal":{"name":"Reproductive Endocrinology","volume":"177 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139334526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of progestagens to preserve pregnancy: modern approaches 使用孕激素保胎:现代方法
Q4 Medicine Pub Date : 2023-09-29 DOI: 10.18370/2309-4117.2023.69.36-40
S. I. Zhuk, I. Us
Review objectives: to summarize current and clinical data on the role of progesterone support in women at risk of miscarriage and premature pregnancy according to the standards of evidence-based medicine. Control of plasma progesterone levels is a fundamental tool for managing the effectiveness of assisted reproductive technologies. The association of a low level of serum progesterone with lower rates of current pregnancy and live birth in cycles of assisted reproductive technologies was revealed. Patients with low serum progesterone on the day of embryo transfer need individualized support of the luteal phase, which involves adding additional doses of progesterone to standard regimens. Vaginal micronized progesterone is currently believed to be the only progestogen that increases the likelihood of a live birth in women with bleeding in early pregnancy which has one or more miscarriages. Vaginal progesterone can be considered for patients with a high risk of miscarriage in the following modes: with vaginal bleeding and a history of one or more miscarriages (threatened miscarriage) – 400 mg twice a day, starting with the detection of vaginal bleeding up to 16 full weeks of pregnancy; with a history of three or more pregnancy losses of unknown etiology (habitual miscarriage) – asymptomatic patients — 200 mg twice a day up to 12 full weeks of pregnancy; patients with vaginal bleeding – 400 mg 2 times a day up to 16 weeks of pregnancy. Currently, there is no evidence of the effectiveness other forms of progesterone and other doses. Conclusions. Vaginal micronized progesterone demonstrated: high efficiency as a standard of luteal phase support; increasing the chance of a live birth in women with a double risk factor for miscarriage (vaginal bleeding in the 1st trimester and ≥1 previous miscarriage); the absence of safety problems for the fetus and the health of newborns when used in the early and late stages of pregnancy.
综述目的:根据循证医学的标准,总结关于孕酮支持在流产和早孕风险妇女中的作用的当前和临床数据。控制血浆孕酮水平是管理辅助生殖技术有效性的基本工具。在辅助生殖技术周期中,血清孕酮水平低与当前妊娠率和活产率低有关。胚胎移植当天血清孕酮低的患者需要个性化的黄体期支持,这包括在标准方案的基础上增加额外剂量的孕酮。 目前,阴道微粒化黄体酮被认为是唯一一种能增加孕早期出血且有一次或多次流产的妇女活产可能性的孕激素。 在以下情况下,流产风险较高的患者可以考虑使用阴道黄体酮:阴道出血并有一次或多次流产史(威胁流产)--每天两次,每次 400 毫克,从发现阴道出血开始,直到怀孕满 16 周;有三次或三次以上不明原因的妊娠流产史(习惯性流产)--无症状患者 †"每天两次,每次 200 毫克,直到怀孕满 12 周;阴道出血患者--每天两次,每次 400 毫克,直到怀孕满 16 周。目前,还没有证据表明其他形式的黄体酮和其他剂量的黄体酮有效。 结论阴道用微粒化黄体酮证明了:作为黄体期支持的标准药物具有很高的效率;增加了具有流产双重危险因素(妊娠前三个月阴道出血和曾经流产过一次)的妇女活产的机会;在妊娠早期和晚期使用对胎儿和新生儿的健康没有安全问题。
{"title":"Use of progestagens to preserve pregnancy: modern approaches","authors":"S. I. Zhuk, I. Us","doi":"10.18370/2309-4117.2023.69.36-40","DOIUrl":"https://doi.org/10.18370/2309-4117.2023.69.36-40","url":null,"abstract":"Review objectives: to summarize current and clinical data on the role of progesterone support in women at risk of miscarriage and premature pregnancy according to the standards of evidence-based medicine. Control of plasma progesterone levels is a fundamental tool for managing the effectiveness of assisted reproductive technologies. The association of a low level of serum progesterone with lower rates of current pregnancy and live birth in cycles of assisted reproductive technologies was revealed. Patients with low serum progesterone on the day of embryo transfer need individualized support of the luteal phase, which involves adding additional doses of progesterone to standard regimens. Vaginal micronized progesterone is currently believed to be the only progestogen that increases the likelihood of a live birth in women with bleeding in early pregnancy which has one or more miscarriages. Vaginal progesterone can be considered for patients with a high risk of miscarriage in the following modes: with vaginal bleeding and a history of one or more miscarriages (threatened miscarriage) – 400 mg twice a day, starting with the detection of vaginal bleeding up to 16 full weeks of pregnancy; with a history of three or more pregnancy losses of unknown etiology (habitual miscarriage) – asymptomatic patients — 200 mg twice a day up to 12 full weeks of pregnancy; patients with vaginal bleeding – 400 mg 2 times a day up to 16 weeks of pregnancy. Currently, there is no evidence of the effectiveness other forms of progesterone and other doses. Conclusions. Vaginal micronized progesterone demonstrated: high efficiency as a standard of luteal phase support; increasing the chance of a live birth in women with a double risk factor for miscarriage (vaginal bleeding in the 1st trimester and ≥1 previous miscarriage); the absence of safety problems for the fetus and the health of newborns when used in the early and late stages of pregnancy.","PeriodicalId":21103,"journal":{"name":"Reproductive Endocrinology","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139334033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of differential expression of genes of structural and regulatory proteins of connective tissue as factors associated with the vaginal prolapse 结缔组织结构蛋白和调节蛋白基因差异表达与阴道脱垂相关因素的分析
Q4 Medicine Pub Date : 2023-09-29 DOI: 10.18370/2309-4117.2023.69.24-29
O. Proshchenko, T.O. Govseev, I. Ventskivska
The article presents data on the differential expression of genes of structural and regulatory proteins of connective tissue (COLIA1, fibronectin, elastin, TGF-β1, LOX) in women with pelvic organ prolapse and stigmas of undifferentiated connective tissue dysplasia (UCTD) compared to patients with prolapse but without UCTD stigmas. Research objectives: analysis of the prognostic significance of differential expression of structural and regulatory genes of connective tissue proteins COLIA1, fibronectin, elastin, TGF-β1, LOX as factors associated with the vaginal prolapse among Ukrainian women. Materials and methods. Vaginal tissue samples were taken from 18 patients at the menopausal age with vaginal prolapse III, IV degree, which required surgical correction during vaginal hysterectomy and/or plastic surgery of vaginal walls. The main group included 11 patients with clinical and anamnestic UCTD stigmas, the comparison group included 7 women without it. Gene expression analysis of structural and regulatory proteins of the extracellular matrix of connective tissue was performed using real-time quantitative polymerase chain reaction. The relative number of transcripts of the studied genes was normalized by the expression level of the GAPDH gene. The data were calculated using the 2–ΔΔCt method. Results. There was decrease in gene expression of the main structural proteins of the extracellular matrix of the connective tissue: COLIA1 (t=-1.7; p=0.044), fibronectin (t=1.66; p=0.047), elastin (t=-1.75, p=0,04), gene of the regulatory protein LOX (t=-1.8, p=0.035) and no statistically significant difference in the TGF-β1 gene in patients with pelvic organ prolapse and clinical and anamnestic UCTD stigmas. Conclusions. Statistically significant lower expression of the genes of the main structural proteins of the extracellular matrix of the connective tissue and the gene of the regulatory protein LOX in patients with pelvic organ prolapse and clinical and anamnestic UCTD stigmas is evidence of the importance of genetically determined pathological remodeling of the connective tissue in the etiology of genital prolapse.
文章介绍了盆腔器官脱垂且伴有未分化结缔组织发育不良(UCTD)症状的妇女与伴有脱垂但无 UCTD 症状的患者相比,结缔组织结构蛋白和调节蛋白(COLIA1、纤连蛋白、弹性蛋白、TGF-β1、LOX)基因表达差异的数据。 研究目的:分析结缔组织蛋白 COLIA1、纤连蛋白、弹性蛋白、TGF-β1、LOX 的结构基因和调控基因的不同表达作为乌克兰妇女阴道脱垂相关因素的预后意义。 材料和方法阴道组织样本取自 18 名绝经期阴道脱垂 III、IV 度患者,这些患者需要在阴道子宫切除术和/或阴道壁整形手术中进行手术矫正。主样本组包括 11 名临床和病理症状均为阴道脱垂的患者,对比样本组包括 7 名无阴道脱垂症状的妇女。使用实时定量聚合酶链反应对结缔组织细胞外基质的结构蛋白和调节蛋白进行了基因表达分析。研究基因转录本的相对数量以 GAPDH 基因的表达水平为标准。数据采用 2-ΔΔCt 法计算。 结果显示结缔组织细胞外基质主要结构蛋白的基因表达量有所下降:COLIA1(t=-1.7;p=0.044)、纤连蛋白(t=1.66;p=0.047)、弹性蛋白(t=-1.75;p=0.04)、调节蛋白 LOX 基因(t=-1.8;p=0.035)的基因表达量均有所下降,而盆腔器官脱垂、临床症状和肛门症状患者的 TGF-β1 基因表达量差异无统计学意义。 结论据统计,在盆腔器官脱垂和临床及症状性尿道下裂患者中,结缔组织细胞外基质主要结构蛋白基因和调节蛋白 LOX 基因的表达量明显较低,这证明了由基因决定的结缔组织病理重塑在生殖器脱垂病因中的重要性。
{"title":"Analysis of differential expression of genes of structural and regulatory proteins of connective tissue as factors associated with the vaginal prolapse","authors":"O. Proshchenko, T.O. Govseev, I. Ventskivska","doi":"10.18370/2309-4117.2023.69.24-29","DOIUrl":"https://doi.org/10.18370/2309-4117.2023.69.24-29","url":null,"abstract":"The article presents data on the differential expression of genes of structural and regulatory proteins of connective tissue (COLIA1, fibronectin, elastin, TGF-β1, LOX) in women with pelvic organ prolapse and stigmas of undifferentiated connective tissue dysplasia (UCTD) compared to patients with prolapse but without UCTD stigmas. Research objectives: analysis of the prognostic significance of differential expression of structural and regulatory genes of connective tissue proteins COLIA1, fibronectin, elastin, TGF-β1, LOX as factors associated with the vaginal prolapse among Ukrainian women. Materials and methods. Vaginal tissue samples were taken from 18 patients at the menopausal age with vaginal prolapse III, IV degree, which required surgical correction during vaginal hysterectomy and/or plastic surgery of vaginal walls. The main group included 11 patients with clinical and anamnestic UCTD stigmas, the comparison group included 7 women without it. Gene expression analysis of structural and regulatory proteins of the extracellular matrix of connective tissue was performed using real-time quantitative polymerase chain reaction. The relative number of transcripts of the studied genes was normalized by the expression level of the GAPDH gene. The data were calculated using the 2–ΔΔCt method. Results. There was decrease in gene expression of the main structural proteins of the extracellular matrix of the connective tissue: COLIA1 (t=-1.7; p=0.044), fibronectin (t=1.66; p=0.047), elastin (t=-1.75, p=0,04), gene of the regulatory protein LOX (t=-1.8, p=0.035) and no statistically significant difference in the TGF-β1 gene in patients with pelvic organ prolapse and clinical and anamnestic UCTD stigmas. Conclusions. Statistically significant lower expression of the genes of the main structural proteins of the extracellular matrix of the connective tissue and the gene of the regulatory protein LOX in patients with pelvic organ prolapse and clinical and anamnestic UCTD stigmas is evidence of the importance of genetically determined pathological remodeling of the connective tissue in the etiology of genital prolapse.","PeriodicalId":21103,"journal":{"name":"Reproductive Endocrinology","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139334011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protection of reproductive health of children: problems of gender and age discrimination 保护儿童生殖健康:性别和年龄歧视问题
Q4 Medicine Pub Date : 2023-09-29 DOI: 10.18370/2309-4117.2023.69.16-23
M. Blikhar, І.М. Zharovska, І.І. Komarnytska, Р.М. Matkivska, Y.V. Mervinska
Research objectives: to investigate the problems of gender and age discrimination in the modern discourse on the protection of children’s reproductive health, to analyze the most important issues including the concept of child reproductive health, normative guarantees in the field of children’s reproductive health, protection of reproductive children’s health in the context of achieving the Sustainable Development Goals of the United Nations, social obstacles to the proper realization of children’s reproductive rights, etc. Materials and methods. A survey was based on the author’s developed questionnaires in order to find out the level of reproductive health and sexual violence among children. The focus group was formed by 540 children: 288 girls and 252 boys aged 15–18 living in Lviv, Ivano-Frankivsk and Zakarpattia regions. The research period covered the years 2021–2023. The error of the obtained results, taking into account the number of respondents, was 2–3.5%. The questionnaires are designed for anonymous and quick filling. Results. Today’s problems and challenges of an environmental, pandemic, and military nature are partially offset by rapid and continuous improvements in social and economic conditions, along with changes in demographics, lifestyles, the environment, and innovations in medical and therapeutic technologies. In general, there is sufficient number of normative protection guarantees that exist at the normative level. However, the problem is manifested in the fact that declarative norms are often ineffective, as they do not entail real guarantees of an organizational and institutional nature regarding the protection and protection of children’s medical rights. Despite the special needs and vulnerabilities that children face, most services are not organized to recognize or meet these needs. Conclusions. It is substantiated that the family is the most important institution in the socialization of a child, and its life experience plays an important role in ensuring that the child is a healthy individual in the broad sense of this concept, which includes physical and psychological criteria. It has been established that characteristics and relationships in the family, especially in the preschool period (the most critical process of children’s development) can positively or negatively affect the structure of the child’s personality. Sudden changes and extraordinary events experienced by the family in the process of adaptation to social changes can cause the family to experience a crisis situation.
研究目标:调查现代儿童生殖健康保护论述中的性别和年龄歧视问题,分析最重要的问 题,包括儿童生殖健康的概念、儿童生殖健康领域的规范保障、在实现联合国可持续发展目 标背景下保护儿童生殖健康、适当实现儿童生殖权利的社会障碍等。 材料和方法。为了了解儿童生殖健康和性暴力的程度,根据作者编制的问卷进行了调查。重点小组由 540 名儿童组成:288 名女孩和 252 名男孩,年龄在 15-18 岁之间,居住在利沃夫州、伊万诺-弗兰科夫斯克州和扎卡尔帕提亚州。研究期限为 2021-2023 年。考虑到受访者人数,所得结果的误差为 2-3.5%。问卷设计为匿名和快速填写。 结果随着人口结构、生活方式、环境的变化以及医疗和治疗技术的创新,社会和经济条件的快速和持续改善部分抵消了当今环境、流行病和军事方面的问题和挑战。总体而言,在规范层面存在足够数量的规范性保护保障。然而,问题表现在宣言性的规范往往是无效的,因为它们并没有为保护和保障儿童的医疗权利提供真正的组织和制度性保障。尽管儿童面临着特殊需求和脆弱性,但大多数服务机构并没有组织起来承认或满足这些需求。 结论。事实证明,家庭是儿童社会化过程中最重要的机构,家庭的生活经验在确保儿童成为广义上的健康个体(包括生理和心理标准)方面发挥着重要作用。已经证实,家庭的特点和关系,尤其是在学龄前时期(儿童成长过程中最关键的时期),会对儿童的人格结构产生积极或消极的影响。家庭在适应社会变革过程中经历的突变和特殊事件会使家庭出现危机状况。
{"title":"Protection of reproductive health of children: problems of gender and age discrimination","authors":"M. Blikhar, І.М. Zharovska, І.І. Komarnytska, Р.М. Matkivska, Y.V. Mervinska","doi":"10.18370/2309-4117.2023.69.16-23","DOIUrl":"https://doi.org/10.18370/2309-4117.2023.69.16-23","url":null,"abstract":"Research objectives: to investigate the problems of gender and age discrimination in the modern discourse on the protection of children’s reproductive health, to analyze the most important issues including the concept of child reproductive health, normative guarantees in the field of children’s reproductive health, protection of reproductive children’s health in the context of achieving the Sustainable Development Goals of the United Nations, social obstacles to the proper realization of children’s reproductive rights, etc. Materials and methods. A survey was based on the author’s developed questionnaires in order to find out the level of reproductive health and sexual violence among children. The focus group was formed by 540 children: 288 girls and 252 boys aged 15–18 living in Lviv, Ivano-Frankivsk and Zakarpattia regions. The research period covered the years 2021–2023. The error of the obtained results, taking into account the number of respondents, was 2–3.5%. The questionnaires are designed for anonymous and quick filling. Results. Today’s problems and challenges of an environmental, pandemic, and military nature are partially offset by rapid and continuous improvements in social and economic conditions, along with changes in demographics, lifestyles, the environment, and innovations in medical and therapeutic technologies. In general, there is sufficient number of normative protection guarantees that exist at the normative level. However, the problem is manifested in the fact that declarative norms are often ineffective, as they do not entail real guarantees of an organizational and institutional nature regarding the protection and protection of children’s medical rights. Despite the special needs and vulnerabilities that children face, most services are not organized to recognize or meet these needs. Conclusions. It is substantiated that the family is the most important institution in the socialization of a child, and its life experience plays an important role in ensuring that the child is a healthy individual in the broad sense of this concept, which includes physical and psychological criteria. It has been established that characteristics and relationships in the family, especially in the preschool period (the most critical process of children’s development) can positively or negatively affect the structure of the child’s personality. Sudden changes and extraordinary events experienced by the family in the process of adaptation to social changes can cause the family to experience a crisis situation.","PeriodicalId":21103,"journal":{"name":"Reproductive Endocrinology","volume":"37 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139334032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Reproductive Endocrinology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1